Apotex Inc. ("Apotex" or the "Company"), the largest Canadian‑based global health company, today announced the commercial launch of Apo‑Semaglutide Injection™ – a generic equivalent ...

Uber drivers in Victoria have something now that no other gig workers in North America do: an honest-to-goodness collective ...

India is the first market where Novo Nordisk faces generic competition for semaglutide — the active ingredient in Ozempic and ...

OneSource Specialty Pharma announced that its partner Dr. Reddy's Laboratories has received a Notice of Compliance from Health Canada for Semaglutide Injection, a generic version of Ozempic. OneSource ...

OneSource Specialty Pharma announced that its partner Orbicular, along with its Canadian front-end partner, has received approval from Health Canada for a generic version of Ozempic (semaglutide ...

Dr Reddy’s generic semaglutide launch in Canada signals cheaper obesity treatment and intensifying global competition against ...

We recently compiled a list of the 10 Best Cancer Stocks to Buy for the Long Term. Dr. Reddy’s Laboratories Limited (NYSE:RDY ...

OneSource supports second generic semaglutide approval in Canada: Our Bureau, Bengaluru Thursday, May 7, 2026, 14:45 Hrs [IST] OneSource Specialty Pharma, a leading specialty phar ...

With the API is entirely produced in house by Dr. Reddy's, OneSource Specialty Pharma to manufacture generic Ozempic version for Canadian market as demand for GLP-1 diabetes therapies rises globally ...

Novo's price cuts lifted Wegovy and Ozempic demand while cheaper GLP-1 therapies expanded India's obesity-drug market.

This modern urban area in China features a decorative sailboat installation placed beside a landscaped pedestrian walkway ...

I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable ...